Gilead Sciences, Inc.
COMPOUNDS FOR INHIBITION OF ALPHA 4 BETA 7 INTEGRIN
Last updated:
Abstract:
The present disclosure provides a compound of Formula (I): ##STR00001## or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processes for preparing compounds of Formula (I), and therapeutic methods for treating inflammatory disease.
Status:
Application
Type:
Utility
Filling date:
22 Oct 2021
Issue date:
19 May 2022